Abstract
7015 Background: CPI-613 is a novel agent that targets mitochondrial metabolism. It inhibits mitochondrial respiration in AML cells and in a single agent phase I study was active for several patien...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
